1994Minimally Invasive Therapy & Allied TechnologiesRequires access

Video-assisted thoracoscopic pleurectomy as therapy for recurring malignant pleural effusion

Godehard Friedel, A. Linder, H. Toomes

Open publisher page 4 citations

Abstract

SummaryRecurring malignant pleural effusion is a common problem with carcinomas invading the pleural surface. Associated symptoms like dyspnoea, cough, and arrhythmia considerably limit the patient's remaining quality of life. Numerous methods have been advocated to induce pleurodesis. The various forms of treatment range from chest tube drainage over instillations of sclerosing substances like tetracyclines, cytostatics, and talc to pleurectomy. None of these treatments, however, so far fulfills the demands for maximum effectiveness with a low rate of recurrence and morbidity. With the introduction of video-assisted thoracoscopic pleurectomy, a method with a low rate of recurrence and morbidity is now at our disposal. During the last 18 months 21 patients with various primary tumours have undergone pleurectomy for pleural carcinomatosis in our hospital. All patients had previously been treated by other methods. In all cases of secondary pleural carcinomatosis a complete parietal pleurectomy was possible. The intra-operative loss of blood was low, with an average of 370 ml. Intra- or post-operative complications did not occur. The mean duration of chest tube drainage was 7 d and the post-operative hospital stay 12 d. During a period of 18 months we have recorded one recurrence requiring no further treatment. These results show that video-assisted thoracoscopic pleurectomy should be undertaken early when other non-invasive methods have failed.

About this research paper

What this paper is about

SummaryRecurring malignant pleural effusion is a common problem with carcinomas invading the pleural surface. Associated symptoms like dyspnoea, cough, and arrhythmia considerably limit the patient's remaining quality of life. Numerous methods have been advocated to induce pleurodesis. The various forms of treatment range from chest tube drainage over instillations of sclerosing substances like tetracyclines, cytostatics, and talc to pleurectomy. None of these treatments, however, so far fulfills the demands for maximum effectiveness with a low rate of recurrence and morbidity. With the introduction of video-assisted thoracoscopic pleurectomy, a method with a low rate of recurrence and morbidity is now at our disposal. During the last 18 months 21 patients with various primary tumours have undergone pleurectomy for pleural carcinomatosis in our hospital. All patients had previously been treated by other methods. In all cases of secondary pleural carcinomatosis a complete parietal pleurectomy was possible. The intra-operative loss of blood was low, with an average of 370 ml. Intra- or post-operative complications did not occur. The mean duration of chest tube drainage was 7 d and the post-operative hospital stay 12 d. During a period of 18 months we have recorded one recurrence requiring no further treatment. These results show that video-assisted thoracoscopic pleurectomy should be undertaken early when other non-invasive methods have failed.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

SummaryRecurring malignant pleural effusion is a common problem with carcinomas invading the pleural surface. Associated symptoms like dyspnoea, cough, and arrhythmia considerably limit the patient's remaining quality of life. Numerous methods have been advocated to induce pleurodesis. The various forms of treatment range from chest tube drainage over instillations of sclerosing substances like tetracyclines, cytostatics, and talc to pleurectomy. None of these treatments, however, so far fulfills the demands for maximum effectiveness with a low rate of recurrence and morbidity. With the introduction of video-assisted thoracoscopic pleurectomy, a method with a low rate of recurrence and morbidity is now at our disposal. During the last 18 months 21 patients with various primary tumours have undergone pleurectomy for pleural carcinomatosis in our hospital. All patients had previously been treated by other methods. In all cases of secondary pleural carcinomatosis a complete parietal pleurectomy was possible. The intra-operative loss of blood was low, with an average of 370 ml. Intra- or post-operative complications did not occur. The mean duration of chest tube drainage was 7 d and the post-operative hospital stay 12 d. During a period of 18 months we have recorded one recurrence requiring no further treatment. These results show that video-assisted thoracoscopic pleurectomy should be undertaken early when other non-invasive methods have failed.

Key concepts: Medicine, Pleurectomy, Pleurodesis, Surgery, Malignant pleural effusion, Pleural effusion, Mesothelioma, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Video-assisted thoracoscopic pleurectomy as therapy for recurring malignant pleural effusion — Research Paper | ScholarLens